IP Library Granted Patent US 7,833,980
Granted Patent B2
US 7,833,980 · App. 12/333,133 · Granted Nov 16, 2010

Compositions and methods for inhibiting cell migration

Assignee: The Burnham Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,833,980
App. No.
12/333,133
Granted
Nov 16, 2010
Kind
B2
Abstract

The finding that Dickkopf1 (Dkk1) is a dual function protein demonstrates a mechanism for the coordination of cell migration and antagonism of Wnt/β-catenin signaling during developmental and pathological processes. The profile of Dkk proteins expressed by human breast cancers correlates with indicators of outcome: Dkk1 associates with markers of poor prognosis whereas expression of single function Dkk2 or Dkk3 (which inhibit Wnt/β-catenin signaling and promote migration, respectively) correlates with phenotypes reflective of good prognosis. Therefore, the pro-migratory activities of Dkk1 and 3 identified here offer new insights into breast cancer progression and a potential avenue for therapeutic intervention.

Claims (3)

1. A method of mobilizing cells comprising contacting the cells with an effective amount of a Dickkopf-1 (Dkk1) protein selected from the group consisting of SEQ ID NO: 8 and SEQ ID NO: 19.

2. The method of claim 1 , wherein the cells do not express endogenous Dkk1.

3. The method of claim 1 , wherein the cells contacted with the Dkk1 protein migrate to the site of a wound.

Assignments (1)
CONFIRMATORY LICENSE Recorded Mar 5, 2024
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 066655/0240 →
Continuity (3)
Division 1178614600 · Apr 10, 2007
Provisional Application 6079063500 · Apr 10, 2006
Related Publication 20090215690A1 · Aug 27, 2009